Acknowledgments
Cho-Phan
This work was made possible by the additional support of individuals from the FDA: Fatima Rizvi; and Syapse: Kathryn Martin, Robin Bauman, Kristi Wilkinson, Autumn Herriman, Donna Rose, Kate Geverd, Cheryl Cho-Phan.Financial Support: This work was supported in part by an appointment to the Research Participation Program at the Office of Clinical Pharmacology/Center for Drug Evaluation and Research, FDA, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U.S. Department of Energy and the FDA. Y. Huang and S. Wang were ORISE fellows contributing to this work.
